BioNxt Solutions Inc.
BNXTF
$0.25
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -63.77% | -29.35% | 7.53% | 8.87% | 29.26% |
| Total Depreciation and Amortization | -71.83% | -88.08% | -74.39% | -66.54% | -63.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 125.97% | 99.99% | 52.06% | 70.76% | 12.40% |
| Change in Net Operating Assets | -1,420.57% | -227.83% | -178.26% | -69.81% | -97.85% |
| Cash from Operations | -34.79% | -68.34% | -55.33% | 20.35% | 29.32% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -9.18% | 136.74% | -64.07% | -77.48% | -55.40% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -45.81% | 48.42% | -71.04% | -70.54% | 33.56% |
| Total Debt Issued | -77.27% | 119.92% | -- | -- | -- |
| Total Debt Repaid | 37.69% | -230.59% | -47,741.94% | -23,950.27% | -1,050.36% |
| Issuance of Common Stock | 141.46% | 40.52% | -22.41% | -82.88% | -61.57% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 412.29% | 561.34% | 667.30% | 493.87% | -87.61% |
| Cash from Financing | 19.66% | 90.90% | 118.06% | -24.21% | 25.04% |
| Foreign Exchange rate Adjustments | -70.59% | 0.00% | -60.71% | 66.67% | 254.55% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -232.24% | 105.18% | 171.61% | -719.93% | 112.67% |